Funding for this research was provided by:
National Institute of Dental and Craniofacial Research (UH2DE025504)
National Institute on Minority Health and Health Disparities (R01MD013719)
Received: 28 December 2020
Accepted: 25 March 2021
First Online: 7 April 2021
: This study was conducted with Institutional Review Board approval (UCSF study number 15-17631) as part of a larger evaluation of WDG’s model of care. Survey respondents provided consent to participate in the study.
: Not applicable.
: KS is the chief operating officer of Willamette Dental Group, the study setting, and on the scientific advisory committee at Skourtes Institute, and acknowledges any competing interests as such. JW is a full-time faculty member at UCSF with practice, teaching, and research activities. He has NIH support as a Principal Investigator and Investigator. He was previously (2012–2015) a paid consultant for Skourtes Institute for development and implementation of CAMBRA, PEMBRA, and data analytics, and Willamette Dental Group for quality improvement. He contributed and disclosed to UCSF the intellectual property for DDS (dental diagnostic system), CAMBRA, and PEMBRA. AK, KH, and EM declare that they have no competing interests.